Johnson & Johnson (J&J) has received a positive recommendation from the UK’s National Institute for Health and Care ...

VML Portugal has announced the launch of VML Health, with pharma communications veteran Mariana Marta dos Santos being ...

For decades, menopause has been swept under the rug, or into the dark corners of clinicians’ offices, often dismissed as ...

The true measure of a medical leader is the courage to act when existing systems fail the patient. This is the professional ...

The career path of a Nurse Practitioner is often envisioned as a straight line: clinical practice, specialization, perhaps a ...

Biogen and Eisai have announced that the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has approved an ...

Gilead has reported that its phase 3 ASCENT-07 trial evaluating Trodelvy (sacituzumab govitecan-hziy) as a first-line ...

InflaRx – a biopharmaceutical company developing anti-inflammatory therapeutics targeting the complement system – has ...

Novo Nordisk has reported that its 2.4mg dosage of semaglutide (Wegovy) demonstrated a reduction in liver injury (steatohepatitis) among patients with metabolic dysfunction-associated steatohepatitis ...

Amgen has reported positive results from its phase 3 VESALIUS-CV trial, which demonstrated that Repatha (evolocumab) ...

AstraZeneca has reported positive full results from its phase 3 NATRON trial evaluating Fasenra (benralizumab) for the ...

Scientists at the University of Edinburgh have identified new drug targets within bacterial cells that could help overcome ...